ChineseInvestors.com, Inc. (CIIX) OptHemp Line Achieves a

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
341
ChineseInvestors.com, Inc. (CIIX) OptHemp Line Achieves a Big Hit with Product Launch

- OptHemp Product Line successfully launched on Amazon and Alibaba
- CBD Magic Hemp Series generated 40,000 views and the purchase of over 91 units just minutes into launch
- CIIX offering is an innovative product line in what CBD Biotechnology believes to be an untapped segment of China’s booming skin care market

ChineseInvestors.com, Inc. (OTCQB: CIIX), in partnership with its foreign enterprise, CBD Biotechnology Co. Ltd. and through its subsidiary ChineseHempOil.com, Inc. has successfully launched its OptHemp product Line via a Top 100 platinum level seller on Amazon.com (NASDAQ: AMZN) and on China’s largest e-commerce retailer Alibaba. During its debut broadcast of “China Taobao Live Broadcasting Celebrity Show,” the company’s “CBD Magic Hemp Series” generated 40,000 views and the purchase of over 91 units just minutes into launch. ChineseInvestors.com CEO Warren Wang indicated in the news release that the product line’s successful initial launch on Taobao “solidifies our belief that Chinese consumers recognize that the anti-inflammatory agents and anti-oxidants contained in hemp-extract can have positive effects on the skin.”

According to Markets Insider (http://nnw.fm/yJ14b), the CBD Magic Hemp Series is the company’s first line of hemp-infused skin care products (the CBDBIO TECH Brightening and Refreshing Moisturizer, CBDBIO TECH Perfecting Shield Primer and CBDBIO TECH Peptide Collagen Solution). The products are intended to bring a moisturizing balance, form a protective layer, provide an even skin tone, and firm the skin while reducing the signs of aging. Different from other skin care lines currently available in China, the products are infused with non-industrial cannabidiol or CBD. While CBD, known as a powerful antioxidant and anti-inflammatory agent, has been widely used in skin care products in western countries for some time, its groundbreaking use in CBD Magic Hemp Series positions the innovative product line in what CBD Biotechnology believes to be an untapped segment of China’s skin care industry.

This product launch and debut with CBD products positions CIIX as an emerging leader in a strong market segment. According to CBD Biotechnology and as reported by Fidelity Investments (http://nnw.fm/kOh7m): “China has one of the world’s largest consumer markets for skin care products. Retail sales of skincare products and make-up products in China reached 169.1 billion yuan and 28.3 billion yuan respectively in 2016, with year-over-year growth of 5% and 12% respectively. Skin care is expected to reach 223.3 billion yuan in 2021 with growth driven by rising awareness of skin health and consumption upgrading Chinese consumers. As one of the first hemp infused skin care brands in China, we are confident that CBD Biotechnology will lead Chinese market, with potential for global expansion.”

For more information, visit the company’s website at www.ChineseInvestors.com

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Chineseinvestors.com Inc. (CIIX) Stock Research Links

CIIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Auction Direct USA Offers Budget-Friendly Used Cars

Updated Category News Views 53

Dollars and Sense: Affordable Cars in Raleigh Listen up, folks. These days, unless you're on the hunt for a fancy ride decked out with every bell and whistle, the idea of nabbing a car under ten grand almost sounds like a fairytale. But Auction Direct USA in Raleigh is making this dream a reality. That’s right, a whole fleet of used cars, all priced under $10,000, is...

Continue Reading
Lennox Faces Pressures Amidst Strong Revenue Growth

Updated Category News Views 118

Revenue Surge but Margin Squeeze Out there in the land of HVAC, Lennox International (NYSE: LII) just dropped its third quarter earnings for 2026. Sure, they raked in a solid $1.6 billion—up a hearty 10%. But all that glitters ain't gold, and the company's operating income took a hit down to $312 million, shedding a cool five percent from last year. Challenges Weighing...

Continue Reading
EWTN’s Docuseries 'In Jesus' Name' Explores Exorcisms

Updated Category News Views 50

The True Stories Behind Exorcisms In the complex landscape of media today, EWTN Studio's latest docuseries, In Jesus' Name, steps into the ring with tales that outstrip Hollywood's beloved fright flicks. Forget about the jumpscares and the special effects next to those greased-up eggs you're munching on. This series drills right to the bone of reality—a candid look at...

Continue Reading
Core Lab's Quarterly Grit: Navigating a Turbulent Market

Updated Category News Views 71

Core Lab's Quarter in Review With the kind of resilience that makes a trader's hands shake ever so slightly less over a coffee, Core Laboratories Inc. heads into the fourth quarter of 2026. This isn't your typical Wall Street story, that's for sure. Watching a solid player like Core navigate the bumpy roads of today's volatile market reminds me of a...

Continue Reading
Small Biz Financing Soars Amid Credit Struggles

Updated Category News Views 64

Record Financing Applications, But Not All is Rosy Diving headlong into this 1West data is like clutching at a double-edged sword. On one side, we've got record-breaking numbers—48,975 financing applications in Q3 alone. That’s a staggering 25% hike over last year. But before you pop the champagne, let's pivot to the other edge: dwindling financial health. With the...

Continue Reading
First Responders Honored in Times Square Hero Ceremony

Updated Category News Views 188

Stepping up to Spotlight Courage In a world that often seems to teeter on chaos, it's those unsung heroes—the first responders—who stand ready to turn panic into repose. October 28th saw Times Square in New York City transform into a beacon of appreciation as the First Responders Children's Foundation (FRCF) applauded nineteen fearless foes of danger. Picture that...

Continue Reading
AEP's $100B Power Plan: Investing in Tomorrow's Energy

Updated Category News Views 75

Electricity Powerhouse Unleashes Ambitious Plan If you thought American Electric Power (NASDAQ:AEP) was just cruising along, think again. This week, they rolled out an eye-popping $100 billion plan to supercharge their infrastructure and meet soaring electricity demands. It’s like they’re building the future of power right in front of our eyes. Third-quarter earnings...

Continue Reading
Oracle's Bold Vision: Targeting $225B Revenue by 2030

Updated Category News Views 132

Oracle Lays Down a Bold Gauntlet Oracle Corporation (NYSE: ORCL) sure knows how to draw the spotlight. With their recent Investor Day in Vegas, they've laid out ambitions that could make even the most seasoned Wall Streeter spit out their coffee. Who would've thought they'd be betting on a whopping $225 billion in revenue by FY30? That's supposed to be a more than 35%...

Continue Reading
Cloopen Group's Private Transition: What Investors Should Know

Updated Category News Views 98

Cloopen Steps Away from Public Market Scene Here's a tale simmering on the corporate backburner: Cloopen Group Holding Limited, that cloud juggernaut over in China, has gone all private on us. The ink is drying on their merger with SummerX Holdings Limited, under the overarching umbrella of SpringX Holdings. So, now this communications outfit has slipped out of the public...

Continue Reading
Long March Reflections: Lesson of Adaptation Endures

Updated Category News Views 50

Ever stood in a place where history feels so heavy you can almost touch it? That's Lazikou, a gorge in southern Gansu, where ninety years ago, young soldiers of China's Red Army faced a seemingly impassable barrier. Yet, they managed to climb, transform a military retreat into legend, and essentially shape the nation's path ahead. It's a feat that still sends ripples...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights on the Growing Aeroderivative Gas Turbine Market

Updated Category News Views 259

Aeroderivative Gas Turbine Market Overview The Aeroderivative Gas Turbine market is experiencing remarkable growth, driven by increasing demands for efficient power generation and technological innovations. According to recent analysis, the market is projected to surge to an estimated value of USD 6.79 billion by 2034, marking a compound annual growth rate (CAGR) of...

Continue Reading
Chain.io Unveils Snowflake Integration for Supply Chain Excellence

Updated Category News Views 149

Chain.io Unveils New Snowflake Connectivity Chain.io has introduced an exciting connected application aimed at boosting the capabilities of supply chain teams. This innovative tool provides seamless access to supply chain data, paving the way for deeper insights and improved operational efficiency. Navigating the Complexities of Supply Chain Data Logistics and supply...

Continue Reading
Antalpha's Exceptional Q3 Performance Highlights Growth Potential

Updated Category News Views 151

Antalpha's Impressive Third Quarter Performance Antalpha Platform Holding Company (NASDAQ: ANTA) has recently unveiled promising financial results for the third quarter of this year. This period has proven pivotal as the company marked an extraordinary 62% growth in revenue over the previous year, highlighting the effectiveness of their Prime lending platform. Rapid...

Continue Reading
Class Action Alert for Block, Inc. Shareholders - What to Know

Updated Category News Views 223

Understanding Class Actions and Your Rights If you've faced losses in your investments with Block, Inc. (XYZ), you may feel overwhelmed and uncertain about your next steps. Class action lawsuits can be an effective way for shareholders like you to seek justice and accountability from companies. The Gross Law Firm is reaching out to encourage affected investors to take...

Continue Reading
Acumen Pharmaceuticals Highlights Innovations in Alzheimer's Research

Updated Category News Views 101

Acumen Pharmaceuticals Advances in Alzheimer’s Research Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a pioneering clinical-stage biopharmaceutical company, is at the forefront of developing a promising new treatment aimed at combating Alzheimer's disease. This innovative approach focuses on targeting soluble amyloid beta oligomers (A?Os), a significant physiological...

Continue Reading